Need help or have questions about your order? Call 510-991-8265Questions about your order? Call 510-991-8265

Sign InShop GLPs
Shop GLPs

Gynecomastia on Testosterone Cypionate: Week-by-Week Timeline of What to Expect

By
Published Updated Last reviewed
4 linked public sourcesEditorial, sourcing, and corrections policy

At a glance

  • Onset timing / Not stated in the label; it says gynecomastia may develop during treatment [1]
  • Persistence / The label says it may occasionally persist [1]
  • Frequency / Listed in adverse reactions without a rate [1]
  • Mechanism / Aromatase converts testosterone to estradiol; excess estrogen action relative to androgen action drives breast growth [2][3]
  • Workup / Breast and testicular exam plus hormone and other labs depending on findings [4]
  • Guideline treatment / SERMs and aromatase inhibitors are not justified in general; surgery is the choice for long-lasting gynecomastia [4]

What does the label say about when gynecomastia appears?

The Depo-Testosterone label names gynecomastia in its adverse reactions section and warns that it "may develop and occasionally persists in patients being treated for hypogonadism" [1]. It gives no onset week or frequency [1].

Why testosterone cypionate can enlarge breast tissue

Aromatase converts androgens to estrogens [2]. Estrogens stimulate breast tissue growth, while androgens inhibit it; most gynecomastia comes from deficient androgen action or excessive estrogen action [3].

HealthRX.com offers testosterone cypionate by prescription.

What to check when a lump or breast tenderness appears

Gynecomastia is benign enlargement of male breast tissue, it is much more common than breast cancer in men, and a careful physical exam can usually tell the two apart [3]. The European Academy of Andrology guideline says assessment should look for an underlying condition and for reversible causes such as an aggravating drug, and should distinguish gynecomastia from other breast lumps, particularly breast cancer [4].

Assessment includes a breast and genital exam with testicular ultrasound and may include hormone and other laboratory tests [4]. Breast imaging may help when the exam is unclear; a suspicious lesion goes straight to core needle biopsy [4]. The Depo-Testosterone label lists carcinoma of the breast in men as a contraindication [1].

What treatment is supported for testosterone-related gynecomastia

For gynecomastia in general, the European Academy of Andrology guideline states that aromatase inhibitors, SERMs and non-aromatizable androgens are not justified in general. It recommends watchful waiting after an underlying cause is addressed or an associated substance is discontinued, and calls surgery the treatment of choice for long-lasting gynecomastia [4].

Frequently asked questions

What does assessment of a breast lump or tenderness involve?
Per the European Academy of Andrology guideline: a breast and genital exam including testicular ultrasound, laboratory tests that may include testosterone, estradiol, hCG and alpha-fetoprotein, imaging when the exam is equivocal, and core needle biopsy for suspicious lesions [4].
Does gynecomastia from testosterone go away on its own?
The label says it may develop and occasionally persists, so persistence is a recognized outcome [1]. The European Academy of Andrology guideline recommends watchful waiting once an underlying cause is treated or an associated substance is discontinued, and surgery for long-lasting gynecomastia [4].
Do aromatase inhibitors or tamoxifen treat testosterone-related gynecomastia?
The European Academy of Andrology guideline states that SERMs, aromatase inhibitors and non-aromatizable androgens are not justified in general for gynecomastia [4].
Is gynecomastia a contraindication on the Depo-Testosterone label?
No. The listed contraindications are hypersensitivity, breast carcinoma in men, known or suspected prostate carcinoma in men, pregnancy, and serious cardiac, hepatic or renal disease. The label says dosage is adjusted according to the patient's response and the appearance of adverse reactions [1].

References

  1. U.S. National Library of Medicine, DailyMed. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) prescribing information. Depo-Testosterone (cypionate) intramuscular, Pharmacia & Upjohn/Pfizer (testosterone cypionate) label
  2. Cooke PS, Nanjappa MK, Ko C, Prins GS, Hess RA. Estrogens in Male Physiology. Physiol Rev. 2017;97(3):995-1043. Estrogens in Male Physiology
  3. Narula HS, Carlson HE. Gynaecomastia--pathophysiology, diagnosis and treatment. Nat Rev Endocrinol. 2014;10(11):684-98. Gynaecomastia--pathophysiology, diagnosis and treatment
  4. Kanakis GA, Nordkap L, Bang AK, Calogero AE, Bártfai G, Corona G, et al. EAA clinical practice guidelines-gynecomastia evaluation and management. Andrology. 2019;7(6):778-793. EAA clinical practice guidelines-gynecomastia evaluation and management
Evidence overview for Gynecomastia on Testosterone Cypionate: Week-by-Week Timeline of What to Expect